Madrigal Pharmaceuticals (MDGL) PT Raised to $309 at Cowen, 'Safety Remains Clean', 'We are very encouraged by today's data'
Tweet Send to a Friend
Cowen analyst Ritu Baral raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $309.00 (from $129.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
